SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-022244
Filing Date
2020-08-14
Accepted
2020-08-14 16:02:15
Documents
93
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_elitepharma.htm 10-Q 870675
2 SERIES J PREFERRED STOCK AND SERIES J COMMON STOCK PURCHASE WARRANT ANTI-DILUTIO f10q0620ex10-57_elitepharma.htm EX-10.57 3667
3 CERTIFICATION f10q0620ex31-1_elitepharma.htm EX-31.1 9452
4 CERTIFICATION f10q0620ex31-2_elitepharma.htm EX-31.2 9435
5 CERTIFICATION f10q0620ex32-1_elitepharma.htm EX-32.1 3783
6 CERTIFICATION f10q0620ex32-2_elitepharma.htm EX-32.2 3726
  Complete submission text file 0001213900-20-022244.txt   5137631

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE eltp-20200630.xml EX-101.INS 862799
8 XBRL SCHEMA FILE eltp-20200630.xsd EX-101.SCH 80692
9 XBRL CALCULATION FILE eltp-20200630_cal.xml EX-101.CAL 66896
10 XBRL DEFINITION FILE eltp-20200630_def.xml EX-101.DEF 218595
11 XBRL LABEL FILE eltp-20200630_lab.xml EX-101.LAB 450718
12 XBRL PRESENTATION FILE eltp-20200630_pre.xml EX-101.PRE 355795
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-15697 | Film No.: 201104911
SIC: 2834 Pharmaceutical Preparations